N. Makino et al., Chronic antisense therapy for angiotensinogen on cardiac hypertrophy in spontaneously hypertensive rats, CARDIO RES, 44(3), 1999, pp. 543-548
Citations number
36
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Objective: We examined the effect of the suppression of plasma angiotensino
gen (AGT) by the intravenous injection of antisense oligodeoxynucleotides (
ODNs) against AGT targeted to the liver on cardiac remodeling in spontaneou
sly hypertensive rats (SHR). The ODNs against rat AGT were coupled to asial
oglycoprotein (ASOR) carrier molecules, which serve as an important method
for regulating liver gene expression. Methods: Male SHR(n=18), and age-matc
hed male Wistar-Kyoto rats (WKY, n=6) were used for this study. At 10 weeks
of age, the SHR were divided into three groups (each group n=6), and the s
ystolic blood pressure (SBP) did not significantly change among them. The c
ontrol SHR and WKY groups received saline, the sense SHR group was injected
with the sense ODNs complex and the antisense SHR group was injected with
the antisense ODNs complex, from 10 to 20 weeks of age. ASOR-poly(L)lysine-
ODNs complex was injected via the tail veins twice a week. Results: At the
end of the treatment, a reduction of hepatic AGT mRNA, cardiac angiotensin
II type 1 receptor mRNA and the plasma AGT concentration was only observed
in the antisense-injected SHR but not in the other groups of SHR and WKY. T
his antisense therapy did not significantly change the mRNA expression for
angiotensin converting enzyme, angiotensin II type 2 receptor and AGT in th
e left ventricle (LV) among all three groups. Although the plasma angiotens
in II (Ang II) concentration significantly decreased to the level of WKY af
ter the antisense therapy, the SEP, LV to body weight ratio and % collagen
volume fraction also showed a reduction, however, these findings were still
larger than in the WKY than in either the sense-injected SHR or control SH
R. Conclusion: The plasma AGT is considered to play a role in the developme
nt of cardiac hypertrophy in SHR, but it has not a complete effects on card
iac remodeling even if the plasma Ang II levels are inhibited because of an
insufficient suppression of hypertension. (C) 1999 Elsevier Science B.V. A
ll rights reserved.